K243417

Substantially Equivalent

RelieVRx

Applicant: Appliedvr
Product code: QRA
Advisory panel: Neurology
Date received: 2024-11-04
Decision date: 2024-12-04
Decision: Substantially Equivalent
Clearance type: Special
Location: Van Nuys, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.